Literature DB >> 24102086

Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery.

Daquan Chen1, Hongyun Yu, Kaoxiang Sun, Wanhui Liu, Hongbo Wang.   

Abstract

In this article, we prepared a dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery by using a degradable pH-responsive ketal derivative, mPEG2000-Isopropylideneglycerol (mPEG-IS, PI) polymer. The purpose of this study is to develop an injectable dual-responsive micellar nanogel system which has a sol-gel phase transition by the stimulation of body temperature with improved stability and biocompatibility as a controlled drug delivery carrier for cancer therapy. The pH-responsive PI was designed with pH-responsive ketal group as hydrophobic moieties and PEG group as hydrophilic moieties. The PI micelles encapsulated paclitaxel (PTX) was fabricated. Then, the PI micelles were formed in a thermo-nanogel. The micellar nanogel could improve the solubility and stability of PTX. The physiochemical properties of PI micelles and micellar nanogel were characterized. The results showed that dual-responsive micellar nanogel could carry out sol-gel transition at 37 °C. The PI polymer can spontaneously self-assemble into micellar structure with size of 100-200 nm. The dual-responsive micellar nanogel could be degraded under lower pH condition. The test in vitro PTX release showed that dual-responsive micellar nanogel could release about 70% for 70 h under pH 5.0 while about 10% release at pH 7.4 and pH 9.0. The dual-responsive micellar nanogel was of lower cytotoxicity and suppressed tumor growth most efficiently. The micellar nanogel will be a new potential dual-responsive drug delivery system for cancer therapy.

Entities:  

Keywords:  Micellar nanogel; PTX delivery; mPEG-IS (PI); pH-responsive micelles; thermoresponsive

Mesh:

Substances:

Year:  2013        PMID: 24102086     DOI: 10.3109/10717544.2013.838717

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  8 in total

Review 1.  Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the art.

Authors:  Govind Soni; Khushwant S Yadav
Journal:  Saudi Pharm J       Date:  2014-04-16       Impact factor: 4.330

Review 2.  Nanogels for Pharmaceutical and Biomedical Applications and Their Fabrication Using 3D Printing Technologies.

Authors:  Hyunah Cho; Udayabhanu Jammalamadaka; Karthik Tappa
Journal:  Materials (Basel)       Date:  2018-02-16       Impact factor: 3.623

Review 3.  Current status of in vivo bioanalysis of nano drug delivery systems.

Authors:  Tingting Wang; Di Zhang; Dong Sun; Jingkai Gu
Journal:  J Pharm Anal       Date:  2020-05-16

4.  Protoporphyrin IX-loaded laminarin nanoparticles for anticancer treatment, their cellular behavior, ROS detection, and animal studies.

Authors:  Yueming Yu; Bingjie Wang; Chunjing Guo; Feng Zhao; Daquan Chen
Journal:  Nanoscale Res Lett       Date:  2019-09-18       Impact factor: 4.703

5.  Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer.

Authors:  Bingjie Wang; Wei Zhang; Xiudi Zhou; Mengna Liu; Xiaoya Hou; Ziting Cheng; Daquan Chen
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

6.  Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy in vivo.

Authors:  Wanfu Men; Peiyao Zhu; Siyuan Dong; Wenke Liu; Kun Zhou; Yu Bai; Xiangli Liu; Shulei Gong; Shuguang Zhang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 7.  Application of Sol-Gels for Treatment of Gynaecological Conditions-Physiological Perspectives and Emerging Concepts in Intravaginal Drug Delivery.

Authors:  Ritu Thapa; Shila Gurung; Marie-Odile Parat; Harendra S Parekh; Preeti Pandey
Journal:  Gels       Date:  2022-02-08

Review 8.  Physically stimulus-responsive nanoparticles for therapy and diagnosis.

Authors:  Fatemeh Farjadian; Soheila Ghasemi; Mohsen Akbarian; Mojtaba Hoseini-Ghahfarokhi; Mohsen Moghoofei; Mohammad Doroudian
Journal:  Front Chem       Date:  2022-09-14       Impact factor: 5.545

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.